Anlotinib for the Treatment of Patients with Locally Advanced or Metastatic Medullary Thyroid Cancer - Concepedia

Concepedia

Publication | Closed Access

Anlotinib for the Treatment of Patients with Locally Advanced or Metastatic Medullary Thyroid Cancer

109

Citations

19

References

2018

Year

Yongkun Sun, Feng Du, Ming Gao, Qinghai Ji, Yuan Zhang, Zhuming Guo, Jun Wang, Xiangjin Chen, Jinwan Wang, Yihebali Chi,

Abstract

Anlotinib demonstrated a durable antitumor activity with a manageable adverse event profile in locally advanced or metastatic MTC.

References

	Year	Citations

Page 1